                         SEQUENCE LISTING

<110>  OBI Pharma Inc.
 
<120>  Method for predicting human immune response

<130>  19P0347

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  696
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  fluorescent protein

<400>  1
atggcccagt ccaagcacgg cctgaccaag gagatgacca tgaagtaccg catggagggc       60

tgcgtggacg gccacaagtt cgtgatcacc ggcgagggca tcggctaccc cttcaagggc      120

aagcaggcca tcaacctgtg cgtggtggag ggcggcccct tgcccttcgc cgaggacatc      180

ttgtccgccg ccttcatgta cggcaaccgc gtgttcaccg agtaccccca ggacatcgtc      240

gactacttca agaactcctg ccccgccggc tacacctggg accgctcctt cctgttcgag      300

gacggcgccg tgtgcatctg caacgccgac atcaccgtga gcgtggagga gaactgcatg      360

taccacgagt ccaagttcta cggcgtgaac ttccccgccg acggccccgt gatgaagaag      420

atgaccgaca actgggagcc ctcctgcgag aagatcatcc ccgtgcccaa gcagggcatc      480

ttgaagggcg acgtgagcat gtacctgctg ctgaaggacg gtggccgctt gcgctgccag      540

ttcgacaccg tgtacaaggc caagtccgtg ccccgcaaga tgcccgactg gcacttcatc      600

cagcacaagc tgacccgcga ggaccgcagc gacgccaaga accagaagtg gcacctgacc      660

gagcacgcca tcgcctccgg ctccgccttg ccctga                                696

